A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
A new experimental KRAS-targeted vaccine shows promise in early trials for preventing pancreatic cancer in high-risk individuals.
2 independently checked trend briefs about this subject, newest first.
headlinez.news detected 2 source-qualified news clusters connected to Aacr between June 24, 2026 and July 17, 2026. They span 1 newsroom category and average 11.5 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
A new experimental KRAS-targeted vaccine shows promise in early trials for preventing pancreatic cancer in high-risk individuals.
A new AACR report finds that while U.S. cancer mortality has dropped significantly since 1991, persistent geographic and racial health disparities remain.